Loading stock data…
CDLX
$0.91+0.02 (+1.91%)
Market ClosedLast close May 1
Cardlytics, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Cardlytics, Inc. in the Communication Services sector is trading at $0.91. The stock is currently near its 52-week low of $0.66, remaining 31.8% below its 200-day moving average. Technical signals show neutral RSI of 42 and bearish MACD signal, explaining why CDLX maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 42) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
METAGOOGLNFLX
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.91
Potential Upside
5%
Whystock Fair Value$0.96
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company provides Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels,...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$54.50M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.93
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
2817.10%
Volume
Today's trading volume
500,793
Recent News
How The Cardlytics (CDLX) Narrative Is Resetting After Guidance Changes And Partner Exits
Cardlytics is back in focus after its latest fair value estimate was trimmed from US$1.29 to US$1.04, pointing to a lower price target in the updated analyst narrative. Much of this reset is being linked directly to Q4 results, Q1 guidance, and the revenue implications of the BofA exit and Bridg divestiture, which have pushed analysts to mark expectations closer to current realities. Reading on, you will see how bullish and bearish voices are framing these changes and how you can track the...
How The Investment Story Is Shifting For Cardlytics (CDLX) After Guidance Reset And Asset Changes
Cardlytics now sits under a reduced US$1.25 price target, with fair value moved from US$1.63 to US$1.29 to keep the model aligned with this new level. Analysts are framing this reset around how quickly the business can adjust after the Q1 guidance change, the BofA exit and the Bridg divestiture, with bulls and bears splitting on what that means for execution risk. As you read on, you will see how this evolving narrative might shape the way you track Cardlytics from here. Stay updated as the...
Cardlytics, Inc. Q4 2025 Earnings Call Summary
Moby summary of Cardlytics, Inc.'s Q4 2025 earnings call
Cardlytics Inc (CDLX) Q4 2025 Earnings Call Highlights: Navigating Challenges and Leveraging ...
Despite a challenging year with revenue declines and the loss of a major partner, Cardlytics Inc (CDLX) focuses on strategic partnerships and technological advancements to drive future growth.
Cardlytics: Q4 Earnings Snapshot
ATLANTA (AP) — Cardlytics, Inc. CDLX) on Wednesday reported a loss of $8.3 million in its fourth quarter. On a per-share basis, the Atlanta-based company said it had a loss of 15 cents.